학술논문
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
Document Type
Article
Author
Diaz, Luis A, Jr ; Shiu, Kai-Keen; Kim, Tae-Won; Jensen, Benny Vittrup; Jensen, Lars Henrik; Punt, Cornelis; Smith, Denis; Garcia-Carbonero, Rocio; Benavides, Manuel; Gibbs, Peter; de la Fourchardiere, Christelle; Rivera, Fernando; Elez, Elena; Le, Dung T; Yoshino, Takayuki; Zhong, Wen Yan; Fogelman, David; Marinello, Patricia; Andre, Thierry
Source
In The Lancet Oncology May 2022 23(5):659-670
Subject
Language
ISSN
1470-2045